CTS2190 Phase I /II Clinical Study in Patients

Clinical trial NCT06224387 · RECRUITING

Trial details

NCT number: NCT06224387
Sponsor: CytosinLab Therapeutics Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumors Pancreatic Cancer Non-small Cell Lung Cancer Triple-negative Breast Cancer

Start date: 2023-06-26
Primary completion: 2025-07-31
Enrollment: 224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.